{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T04:05:48Z","timestamp":1743134748776,"version":"3.40.3"},"reference-count":30,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"accepted":{"date-parts":[[2023,9,18]]},"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1136\/ejhpharm-2023-003878","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T16:35:44Z","timestamp":1707496544000},"page":"143-148","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of the accuracy of estimated free phenytoin concentrations in a mixed patient population"],"prefix":"10.1136","volume":"32","author":[{"given":"Niamh S","family":"Horton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2324-297X","authenticated-orcid":false,"given":"Sally L","family":"Hanton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leanne","family":"Sheppard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Birch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carrie A","family":"Chadwick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,10,6]]},"reference":[{"key":"2025032704500671000_32.2.143.1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4212\/cjhp.v69i4.1573","article-title":"Predictive performance of the Winter\u2013Tozer and derivative equations for estimating free phenytoin concentration","volume":"69","author":"Cheng","year":"2016","journal-title":"Can J Hosp Pharm"},{"key":"2025032704500671000_32.2.143.2","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200206000-00009"},{"key":"2025032704500671000_32.2.143.3","doi-asserted-by":"publisher","DOI":"10.1007\/BF01059685"},{"key":"2025032704500671000_32.2.143.4","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2009.50.4.517"},{"key":"2025032704500671000_32.2.143.5","doi-asserted-by":"crossref","DOI":"10.1177\/1060028013505273","article-title":"Author response to Brown et al characterization of free phenytoin concentrations in neurointensive care unit patients using a revised winter-Tozer equation","volume":"47","author":"Kane","year":"2013","journal-title":"Ann Pharmacother"},{"key":"2025032704500671000_32.2.143.6","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6947-12-7"},{"key":"2025032704500671000_32.2.143.7","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.27"},{"key":"2025032704500671000_32.2.143.8","doi-asserted-by":"crossref","first-page":"822","DOI":"10.5858\/1999-123-0822-FDM","article-title":"Free drug measurements. When and why? an overview","volume":"123","author":"Soldin","year":"1999","journal-title":"Arch Pathol Lab Med"},{"key":"2025032704500671000_32.2.143.9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2165\/00003088-198400091-00009","article-title":"Free level monitoring of antiepileptic drugs. clinical usefulness and case studies","volume":"9 Suppl 1","author":"Perucca","year":"1984","journal-title":"Clin Pharmacokinet"},{"key":"2025032704500671000_32.2.143.10","unstructured":"BNF: phenytoin. Available: https:\/\/bnf.nice.org.uk\/drug\/phenytoin.html#indicationsAndDoses [Accessed 15 Dec 2022]."},{"key":"2025032704500671000_32.2.143.11","unstructured":"Patient safety alert NHS\/PSA\/W\/2016\/010 risk of death and severe harm from error with Injectable phenytoin. 2016. Available: https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2019\/12\/Patient_Safety_Alert_-_Risk_of_error_with_injectable_phenytoin_v2.pdf [Accessed 15 Dec 2022]."},{"key":"2025032704500671000_32.2.143.12","first-page":"312","article-title":"Pharmacokinetic considerations in phenytoin pharmacotherapy: preventing overdoses and underdoses","volume":"62","author":"Profeta","year":"1995","journal-title":"Mt Sinai J Med"},{"key":"2025032704500671000_32.2.143.13","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/106002809703100301","article-title":"Revised Winter\u2013Tozer equation for normalized phenytoin concentrations in trauma and elderly patients with hypoalbuminemia","volume":"31","author":"Anderson","year":"1997","journal-title":"Ann Pharmacother"},{"key":"2025032704500671000_32.2.143.14","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1177\/1060028017707541","article-title":"Characterization of free phenytoin concentrations in end-stage renal disease using the Winter-Tozer equation","volume":"51","author":"Soriano","year":"2017","journal-title":"Ann Pharmacother"},{"key":"2025032704500671000_32.2.143.15","doi-asserted-by":"crossref","first-page":"461","DOI":"10.4140\/TCP.n.2017.461","article-title":"Prediction accuracy of Winter-Tozer equations to estimate free phenytoin concentrations in non-critically ill hospitalized patients","volume":"32","author":"Khan","year":"2017","journal-title":"Consult Pharm"},{"key":"2025032704500671000_32.2.143.16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2165\/00003088-199018020-00004","article-title":"Pharmacokinetic drug interactions with phenytoin (part I)","volume":"18","author":"Nation","year":"1990","journal-title":"Clin Pharmacokinet"},{"key":"2025032704500671000_32.2.143.17","unstructured":"ACB mailbase. Available: https:\/\/www.jiscmail.ac.uk\/cgi-bin\/webadmin?A1=ind01&L=acb-clin-chem-gen [Accessed Dec 2022]."},{"key":"2025032704500671000_32.2.143.18","unstructured":"Pathology harmony reference ranges, Available: https:\/\/www.acb.org.uk\/our-resources.html [Accessed 15 Dec 2022]."},{"key":"2025032704500671000_32.2.143.19","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199109000-00004"},{"key":"2025032704500671000_32.2.143.20","unstructured":"Winter ME , Tozer TN . Phenytoin. In: Evans WE , Schentag JJ , Jusko WJ , eds. Applied pharmacokinetics: principles of therapeutic drug monitoring. Washington: Applied Therapeutics, Inc, 1987: 493\u2013539."},{"key":"2025032704500671000_32.2.143.21","doi-asserted-by":"publisher","DOI":"10.1177\/106002809502907-802"},{"key":"2025032704500671000_32.2.143.22","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200106000-00014"},{"key":"2025032704500671000_32.2.143.23","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1093\/clinchem\/46.8.1132","article-title":"Evidence-based implementation of free phenytoin therapeutic drug monitoring","volume":"46","author":"Burt","year":"2000","journal-title":"Clin Chem"},{"key":"2025032704500671000_32.2.143.24","doi-asserted-by":"publisher","DOI":"10.1177\/1060028016628166"},{"key":"2025032704500671000_32.2.143.25","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1177\/0310057X1504300515","article-title":"Anti-seizure prophylaxis in critically ill patients with traumatic brain injury in an intensive care unit","volume":"43","author":"Sundararajan","year":"2015","journal-title":"Anaesth Intensive Care"},{"key":"2025032704500671000_32.2.143.26","doi-asserted-by":"publisher","DOI":"10.1177\/1060028015627468"},{"key":"2025032704500671000_32.2.143.27","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199404000-00005"},{"key":"2025032704500671000_32.2.143.28","unstructured":"ClinCalc . Phenytoin correction. Available: https:\/\/clincalc.com\/Phenytoin\/Correction.aspx [Accessed 15 Dec 2022]."},{"key":"2025032704500671000_32.2.143.29","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-198804000-00002"},{"key":"2025032704500671000_32.2.143.30","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-199702000-00001"}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2023-003878","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T11:55:09Z","timestamp":1743076509000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2023-003878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,6]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2,21]]},"published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10.1136\/ejhpharm-2023-003878"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2023-003878","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"type":"print","value":"2047-9956"},{"type":"electronic","value":"2047-9964"}],"subject":[],"published":{"date-parts":[[2023,10,6]]}}}